SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Florence Griffith Joyner

PatientFlorence Griffith Joyner
Date of birth1989-12-21
IdentifiersMRN HR-ML033-SYN; SSN (made up) 000-33-2648
Document date2026-05-05
AuthorCeleste Vanterpool, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

EEG and MRI results and epilepsy consultation. [S]

History of Present Illness

Ms. Griffith Joyner returns two weeks after her first visit. The sleep-deprived EEG two days after that visit showed intermittent left frontal sharp waves and slowing. MRI of the brain six days after the visit, with susceptibility-weighted imaging, shows a single 1.4 cm cavernous malformation in the left orbitofrontal cortex with a hemosiderin rim and an adjacent developmental venous anomaly, and no other lesion. Dr. Mehta-Sorensen of the epilepsy service saw her this morning. She has had no further seizure, spell or headache. She has not driven, showers rather than bathes, and has not swum. The records of her earlier seizure care have been requested and have not arrived. She is not pregnant (negative test at the first visit) and is not planning a pregnancy now. She has had no thoughts of self-harm. [S]

ElementDetail
EEGLeft frontal sharp waves and focal slowing
MRISingle 1.4 cm left orbitofrontal cavernous malformation with a hemosiderin rim; no other lesion on susceptibility-weighted imaging
Since the last visitNo seizure; not driving
CoordinationEpilepsy consultation today; neurosurgical opinion requested
Her questionsWhether this is epilepsy, whether the lesion can be removed, and when she can train and drive

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever or weight change
NeurologicalNegativeNo seizures, spells, headache, weakness or change in smell or vision
MusculoskeletalNegativeMuscle aches after the seizure have gone
GenitourinaryNegativeRegular periods; not pregnant
PsychiatricPositiveWorried about another seizure in public; PHQ-9 3; no thoughts of self-harm

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Levetiracetam 500 mg oral tablet, one tablet by mouth twice dailyOne tablet twice dailyOral route2026-05-05activeS
Folic acid 0.4 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-05-05activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-05-05Body height170cmS
2026-05-05Body weight61.2kgS
2026-05-05Body mass index (BMI) [Ratio]21.2kg/m2S
2026-05-05Systolic blood pressure110mm[Hg]S
2026-05-05Diastolic blood pressure68mm[Hg]S
2026-05-05Heart rate58/minS
2026-05-05Respiratory rate14/minS
2026-05-05Body temperature36.6CelS
2026-05-05Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S

Physical Exam

Vital signs recorded on 2026-05-05; see the Vital Signs section. [S]

SystemFinding
GeneralFit and well; weight 61.2 kg; blood pressure 110/68, pulse 58
NeurologicalAlert and oriented; smell intact to coffee in each nostril; cranial nerves, strength, reflexes, sensation, coordination and gait normal
MouthNo tongue or mouth injury
PsychiatricComposed and attentive; asks precise questions

Problems

ProblemClinical statusVerificationCodeProvenance
Generalized tonic-clonic seizure on a flight two and a half weeks ago, in a 36-year-old woman who was observed overnight in hospital elsewhere and has had treatment for seizures in the past, records requested; no antiseizure medication now; normal examination today. Evaluated as a new seizure: EEG and MRI of the brain with susceptibility-weighted imaging ordered, neurology (epilepsy) review booked, and no drivingresolvedconfirmed R56.9S — Synthetic presenting problem anchored to her publicly reported seizure on a flight; superseded by the diagnosis at the epilepsy consultation.
Focal epilepsy with structural cause: focal to bilateral tonic-clonic seizure from a left orbitofrontal cavernous malformation, with left frontal epileptiform discharges on EEG; epilepsy under the ILAE 2014 practical definition (an unprovoked seizure with a recurrence risk above 60% from an epileptogenic lesion, and earlier seizures by history); synthetic modern detail linked to her publicly reported seizures and the coroner's findingactiveconfirmed G40.209S — Synthetic seizure type, EEG and classification; the seizures and the cavernous angioma of the left orbital frontal cerebrum are documented (D).
Solitary cerebral cavernous malformation, 1.4 cm, left orbitofrontal cortex, with a hemosiderin rim and an adjacent developmental venous anomaly, no other lesion on susceptibility-weighted imaging (sporadic pattern); no acute hemorrhageactiveconfirmed Q28.3S — Synthetic imaging detail; the coroner reported a congenital cavernous angioma of the left orbital frontal cerebrum (D).

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryBlood count, electrolytes, glucose, calcium, magnesium, kidney and liver tests, creatine kinase, pregnancy testAt presentation after a seizureUp to dateAll normal at the first visit; pregnancy test negative
ImagingEEG (sleep-deprived)After a first seizure, as soon as practicalUp to dateTwo days after the first visit: left frontal sharp waves and focal slowing
ImagingMRI of the brain, epilepsy protocol with susceptibility-weighted imagingAfter a first seizureUp to dateSix days after the first visit: single left orbitofrontal cavernous malformation with a hemosiderin rim
ExaminationSeizure classification and diagnosis of epilepsyWhen EEG and imaging are availableCompleted todayFocal to bilateral tonic-clonic seizure; focal epilepsy with structural cause (ILAE 2014: one unprovoked seizure with recurrence risk above 60%)
ReferralNeurology (epilepsy)Within two weeks of a first seizureCompleted todaySeen this morning; recommendations in the consultation note
ReferralNeurosurgical evaluation of an epileptogenic cavernous malformationWhen a cavernous malformation causes epilepsyOrderedRequested today, within three weeks
Medication safetyAntiseizure medication choice for a woman who could become pregnantAt the start of treatmentCompleted todayLevetiracetam 500 mg twice daily; valproate avoided; no contraceptive interaction
Medication safetyFolic acidDaily for anyone taking an antiseizure medication who could become pregnantCompleted today0.4 mg daily started
Self-managementContraception and pregnancy planningAt the start of treatment and yearlyCompleted todayNo pregnancy planned; any method is compatible with levetiracetam; plan a pregnancy with the epilepsy team
SurveyMood and behavior on levetiracetam (PHQ-9)Before starting and at each visitCompleted todayPHQ-9 3 before the first dose
Self-managementDriving restriction and the California physician reportFrom the first seizure until clearedUp to dateNot driving; the report California requires was sent after the first visit
Self-managementSeizure safety: water, heights, sleep and first aidAt diagnosis and each visitCompleted todayShowers only; swimming only with a companion who knows first aid; no climbing or working at height; written seizure action plan
Self-managementNocturnal seizure detectionWhen seizures may occur in sleepOrderedWrist-worn detection watch ordered
Self-managementSUDEP counselingAt diagnosis of epilepsyDeferredNot discussed today: the visit was taken up by the diagnosis, the medication and the surgical question. A deviation from the AAN/AES guideline, which calls for the discussion at diagnosis. Corrective action: booked as the first item at the next visit in three weeks

Goal progress:

Guideline basis: Krumholz A, et al. Evidence-based guideline: Management of an unprovoked first seizure in adults. Neurology 2015;84(16):1705-1713 (PMID 25901057) (2015); Fisher RS, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014;55(4):475-482 (PMID 24730690) (2014); Akers A, et al. Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery 2017;80(5):665-680 (PMID 28387823) (2017); Harden C, et al. Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors. Neurology 2017;88(17):1674-1680 (PMID 28438841) (2017); Pack AM, et al. Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM. Neurology 2024;102(11):e209279 (PMID 38748979) (2024); Beniczky S, et al. Automated seizure detection using wearable devices: A clinical practice guideline of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology. Epilepsia 2021;62(3):632-646 (PMID 33666944) (2021); Governor's message returning Senate Bill 357 without signature (physician reporting of disorders characterized by lapses of consciousness remains mandatory under Health and Safety Code section 103900) (2024); Depression and Suicide Risk in Adults: Screening (2023)

Follow-up: Neurosurgical opinion within three weeks; primary care review in three weeks to check levetiracetam, mood and the surgical plan, and to discuss SUDEP. Call at once for another seizure; call emergency services for a seizure lasting five minutes or more. Next scheduled visit 2026-05-27: three weeks on levetiracetam: mood and side effects, the neurosurgical opinion and surgery date, SUDEP and safety counseling. [S]